TrialJournal of clinical pharmacology2023

Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open-Label, Single-Dose, Parallel Group Study.

Ivy Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.